Supplementary Figure S6 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3

2026 Open access

Read full text Summarise with VIRAT
Authors: Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg, Anne Paulien Drenth, Jessica Lee, Catrin Lutz, Lea Dörner, Ellen Wientjens, Sjoerd Klarenbeek, Ji‐Ying Song, Hyeonjin Moon, Stefano Annunziato
+9 more Natalie Proost, Bjørn Siteur, Jeffrey S. Ross, Marieke van de Ven, Olaf van Tellingen, Shridar Ganesan, Lodewyk F.A. Wessels, Daniel Zingg, Jos Jonkers
DOI: 10.1158/0008-5472.31744776
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Data supporting the functional in vitro and in vivo characterization of E18-truncated FGFR3 fusions involving ADD1, TNIP2, and JAKMIP1

Fields of Study & Subjects

Fibroblast Growth Factor Research Sarcoma Diagnosis and Treatment Cancer Mechanisms and Therapy

Publication details

Publication date
16 March 2026
Language
EN